The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Lyxor US$ 10Y Inflation Expectations UCITS ETF - Acc: Net Asset Value(s)

13 Nov 2019 17:07

Lyxor US$ 10Y Inflation Expectations UCITS ETF - Acc (INFG LN) Lyxor US$ 10Y Inflation Expectations UCITS ETF - Acc: Net Asset Value(s) 13-Nov-2019 / 18:06 CET/CEST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


Net Asset Value(s)

FUND: Lyxor US$ 10Y Inflation Expectations UCITS ETF - Acc

DEALING DATE: 12-Nov-2019

NAV PER SHARE: USD: 103.5578

NUMBER OF SHARES IN ISSUE: 1921000

CODE: INFG LN

ISIN: LU1390062831


ISIN:LU1390062831
Category Code:NAV
TIDM:INFG LN
Sequence No.:28959
EQS News ID:912251
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.